The latest filing does not contain sufficient reviewed comparable structured data
Last SEC check
Sep 13, 2026
Filing → research
1 min
Data basis
Official SEC · no quote feed
Component status
Filing EvidenceResearch CurrentOfficial SEC filing history is available
Structured FinancialsSource LimitedThe latest filing model has no reviewed comparable financial mapping · NO_CURRENT_COMPARABLE_STATE
Filing AnalysisSource LimitedNo filing analysis job is currently running · NO_CURRENT_COMPARABLE_STATE
Fundamental StateSource LimitedFundamental State depends on validated comparable financial metrics · NO_CURRENT_COMPARABLE_STATE
RESEARCH SNAPSHOTInMed Pharmaceuticals Inc.'s latest supported as-filed period reports revenue of $820,188. Every value below links to its SEC accession and metric lineage.
INSIDER STATE / 90DRecent disclosed activity
Open-market purchases
0
Sales
0
Distinct buyers
0
Repeat buyer
NO
Conservative Form 4 classification · not a sentiment label
Flagship analysis / V3
What changed?
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q0001213900-26-05292011 governed changes · top 7 shown
01
MEDIUM IMPORTANCEFinancial Value100TH HISTORICAL PCTL · N=4
Current liabilities increased 20.2%
Current liabilities changed +20.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
Working capital / assets changed +194 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed -10.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-03-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.